Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CosmoFrance is a medical device company specializing in aesthetic medicine and minimally invasive tools. Founded in 1997 and headquartered in Miami, the company is best known for introducing the DermaSculpt microcannula to the US market. This technology revolutionized filler injections by reducing trauma, bruising, and downtime for patients. Their portfolio includes advanced systems for Platelet-Rich Fibrin (EZ PRF), microneedling devices like CosmoPen, and various skin rejuvenation technologies. Beyond product distribution, CosmoFrance provides extensive training and education for medical professionals through its academy. The company focuses on providing high-quality, innovative solutions for dermatologists and plastic surgeons.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CosmoFrance.